Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD
NCT: NCT07770867 · RECRUITING
광고
NCT IDNCT07770867
상태RECRUITING
시작일2026-09-15
SponsorNeudive Inc. (INDUSTRY)
First posted
Last updated
간략 요약
The purpose of this study is to evaluate the safety of NDTx-03 used together with treatment as usual (TAU) and to determine whether NDTx-03 plus TAU is more effective than TAU alone in improving social situation recognition and interaction in children and adolescents with autism spectrum disorder (ASD) or social communication disorder (SCD).
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.